"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

Trial ID or NCT#

NCT05410509

Status

not recruiting iconNOT RECRUITING

Purpose

Multi-center, single arm, prospective trial to estimate safety, feasibility, technical outcomes, and clinical outcomes of percutaneous cryoablation with neo-adjuvant trans-arterial embolization of the tumor in patients with T1b renal cell carcinoma. Continuous safety monitoring will be performed with stopping rules for patient accrual or study continuation.

Official Title

"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Nishita Kothary, MD
Nishita Kothary, MD
Interventional radiologist
Professor of Radiology (Interventional Radiology)
Andrew Picel
Andrew Picel
Interventional radiologist
Clinical Associate Professor, Radiology

Contact us to find out if this trial is right for you.

Contact

Christopher Neil Dominguez

View on ClinicalTrials.gov